DiPersio receives awards recognizing contributions to cancer care, research
Oncologist honored for outstanding work on leukemia
DiPersio
John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Endowed Professor of Oncology and director of the Division of Oncology at Washington University School of Medicine in St. Louis, has been named by OncLive as part of the Giants of Cancer Care inductee class of 2022.
The Giants of Cancer Care honor recognizes oncologists who have made groundbreaking contributions to research and clinical practice. OncLive is a news and multimedia resource for oncology professionals. DiPersio, one of 14 honored this year, was recognized for his contributions to the understanding and treatment of leukemia.
DiPersio — who also serves as deputy director of Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine — is a leader in developing novel therapies for leukemia and in understanding how such therapies work. Among other accomplishments, he has developed strategies to optimize CAR-T cell therapies, a type of cell-based immunotherapy that attacks cancer cells. His work also includes improving management of graft-versus-host disease, a sometimes life-threatening condition that some patients develop after a stem cell transplant.
